Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash & Equivalents: 2023

Historic Cash & Equivalents for Sagimet Biosciences (SGMT) over the last 1 years, with Dec 2023 value amounting to $75.1 million.

  • Sagimet Biosciences' Cash & Equivalents fell 24.38% to $77.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $77.0 million, marking a year-over-year decrease of 24.38%. This contributed to the annual value of $75.1 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Sagimet Biosciences' Cash & Equivalents is $75.1 million.
  • Over the past 5 years, Sagimet Biosciences' Cash & Equivalents peaked at $75.1 million during FY2023, and registered a low of $75.1 million during FY2023.
  • Its 1-year average for Cash & Equivalents is $75.1 million, with a median of $75.1 million in 2023.